Phase I study of ALX-0761 for the treatment of inflammatory diseases
Latest Information Update: 13 Jun 2014
At a glance
- Drugs Sonelokimab (Primary)
- Indications Inflammation; Psoriasis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Jun 2014 New trial record